[Contribution of vastarel 20 mg (trimetazidine) in the treatment of vertigo: synopsis of clinical trials].
Bouccara
D
D
Service ORL et Chirurgie Cervico-Faciale, Hôpital Beaujon.
D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008575:Meniere Disease / Q000188:drug therapy; D014292:Trimetazidine / Q000008:administration & dosage / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014717:Vertigo / Q000188:drug therapy*
D014665:Vasodilator Agents; D014292:Trimetazidine
Intérêt de vastarel 20 mg (trimétazidine) dans le traitement des vertiges. Synthèse des études cliniques.